Evaluate the Effect of Orelabrutinib on Cardiac Repolarization in Healthy Subjects
Clinical trial NCT05660720 · UNKNOWN
Trial details
- NCT number
- NCT05660720
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-19
- Primary completion
- 2023-06-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.